Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So. Cost of implants is $79k. And each implants costs about $450 to make.
So they only sold about 175 to CTL.
About 58 a month.
Not exactly killing it. Lol
So, when is the Zimmer buyout happening? Tick Tock!!
Ready to admit defeat yet?
Thought I would check in. I see that nothing has changed!
Also,
KYOCERA acquires Renovis Surgical Technologies as as asset purchase
https://orthostreams.com/2019/01/kyocera-acquires-renovis-surgical-technologies-as-as-asset-purchase/?awt_l=MaYLw&awt_m=3a.372vf_aDr7UU
'Renovis has developed an advanced bearing surface technology for joint replacement products. Kyocera’s global strength and expansive research and development capabilities will accelerate the growth of these valuable technologies.'
No no. You have repeatedly said how the cages will revolutionize the spine industry when Zimmer buys Amedica.
We all know the design of cages are all similar and it’s always been about the material. Now you are backing off
Your claims. Wow. !!!
Amedica just cut its revenue by 80%. Sounds like a recipe for disaster to me. Did they cut their overheads to accommodate. Nope!! Even if you take sales and marketing out, still in the red.
Huh. After all these years now you tell us there is nothing special about SiN interbody cages. Lol. I’m confused.
“There is nothing special about Valeos designs. Every spinal company out there has some.form of solid implant and many of them incorporate porous tech. This asset in of itself is not special”
Even Ladenburg Thalmann is dropping them!
November 1, 2018
AMEDICA CORPORATION
terminating Coverage
We are terminating coverage of Amedica Corporation due to a reallocation of analyst resources. Our last report was on November 27, 2017 and the rating was Neutral.
Effective upon termination of coverage our last recommendation and estimates issued on AMDA should not be relied upon going forward.
In addition to normal economic and market risk factors that impact most all equities, we believe that the primary risks to our recommendation and price target of an investment in Amedica Corp. shares include, but are not limited to: persistent cash burn, competitive intellectual property advances, slowed product development, product liability claims, disappointing data, industry consolidation, and management and Board
You have no verifiable information that Amedica signed a design and development deal. Your only verifiable information is that certain people worked at Zimmer and AMDA. hardly proof that there is a pending merger or buyout.
Basically this is a discussion board on what stocks would be good to invest in. If you put your money in the bank in the last 2 years you would have made more $$ than in AMDA. Now, that is verifiable evidence.
A anonymous quote from 7 years ago. Really? Sound as bad as CNN ‘sources say....’ unbelievable that you are using that !
The only evidence is when Zimmer actually buys ANDA. Other than that, it’s all speculation. I’ve been in the Spine industry for 20 years and everyone is connected in some fashion, since it’s a small community.
And besides, non of your ‘evidence’ has come true. At least I called the CTL buyout, which actually happened.
Er, I think it’s a joke .....
Lol. With SiN granules on the condom they can market it as a rough rider.
Doesn’t make sense. Like I said, if it was such a wonderful product, there would have been a bidding war. Zimmer could snatch up AMDA for $20mil and that would be chump change for them. Even if they bought the company and scrapped the product, nobody at Zimmer would care. Just their R&D budget is ~$367 million alone.
Company’s know when there is a ground breaking product out there. This is not it and every prediction about Zimmer has not materialized!
So. I think we can safely assume that Zimmer is not going to buy Amedica. If you think rationally, if SIN was this great material, surely one of the big ortho company’s would have snapped it up years ago, especially at this cheap price. Medtronic, K2M and others passed on SIN. Does Zimmer know something they don’t ? Unlikely. You know they the big ortho would have investigated the material before passing. I agree, the material had good properties, but most surgeons I have spoken to don’t want to put a hard ceramic object in the spine.
Wouldn’t CTL be the ones attempting to get Japanese FDA clearance?Amedica is just a OEM. CTL now ownes the spine line.
Reports are 9 years old!
You can’t replace a titanium screw with a ceramic one. Maybe surface treat it, but a ceramic screw would eventually break. You could make the abutment out of SIN.
It’s been years and still nothing. So I highly doubt Zimmer will work with them. They would have acquired the whole company by now before CTL got involved. $10 million is nothing to than!! They could buy the company with their petty cash. It’s a tiny acquisition. Look how quick the CTL deal closed.
I think this horse has run it’s race. I don’t think we will hear anything for a long while. Highly doubt Zimmer will even consider AMDA at this stage.
Even so, no FDA approval has been submitted. So still going to take at least over a year just for approval.
What dental revenue? Have they even submitted a 510k yet? Going to take years.
Like the Space Shuttle Challenger. Can’t get into orbit :-/
I believe so. They put infused diamond granules in SiN but don’t think this helped with SiN on SiN. Wasn’t an issue on poly.
What is Amedica going to do about the squeaking of their SiN femoral head?
So you mean the Zimmer deal is dead?
Sales and marketing was about $4.5M. So can remove that.
Their new sales would now be about $1.7M. Less COGs, R&D, general and admin. =$11M
How is this going to work?
Up to 55%. How so?
Still costs the same to manufacture an implant. Still need machinists, packaging and labeling, inspection, QA etc.
They may be able to lay some people off, but you still need the same infrastructure to produce. I don’t see a large cost saving.
Please explain how you got that?
Not if they cut their revenue model by 80%
No one is using metal on metal hips anymore. Recalled and lawsuits.
Like is said for the hundredth time. As a investor you need to look at market trends and where the volume is.
As an investor I am interested in making money. I am not here to try to convince the world that metals are bad. Just seems like a lot of energy going into something you can’t chance.
Yes. We do brain scans and blood tests on patients every 6 months. All clear.
We have been using cobalt chrome rods in our scoliosis patients for over 15 years. Have never had any issues with corrosion in thousands of patients. Still using co cr today.
Never had a surgeon mention corrosion issues to me. Think it’s overblown.
Unless there is a big public outcry, they will continue to use it.
We use Co Cr rods in scoliosis surgery’s all the time. Gives a much better correction than titanium rods as it holds the shape better and does not spring back like titanium. Much better than titanium for the patient. So you need to look at all aspects.
Patients don’t choose what implants they get to use. It’s the surgeons who do that.
I’m not saying there are no issues. What I’m saying is they there is no general concern in the surgery circles with metals, so they are going to continue to use it.
Like I keep on saying. It’s all about what the market demands! Economics 101. I don’t know how else or explain this.
Nobody is using ceramic on ceramic anymore. So ceramic on poly is not an issue.
And besides. SiN is an unproven material in joints. There is now way Zimmer would switch to SIN. Like I keep on saying. Market doesn’t care. They would need to do a clinical study that’s going to take years if they decide to do this.
So they are going to replace ZTA zirconia with SIN. Why would they do that?
You keep on going on about the Zimmer buyout. I think it’s very obvious that they are not going to buy Amedica or else it would have happened already before they sold off Spine.
No surgeons I know of are complaining about Co Cr or titanium being an issue. It’s all about how the market adopt new technology and for some reason you don’t want to recognize that SIN is not being accepted. Need to look at the facts and not speculation.
Can someone explain the business model going forward?
Taking a 88% revenue cut on their sales does not sound like a great business model. How are they going to afford the overheads? I guess they will be laying off the customer service people and obviously the sales reps.
But they are going to have to see a whole bunch more cages to become profitable.
The SiN coating still needs to be tested and validated. They had some titanium screws and a knee coated by an outside lab. PVD physical vapor depositions are very thin and i highly doubt it will have any anti microbial effect according to Amedicas theory’s on solid SiN. Protein bonding etc.
It is only microns thick and smooth. I highly doubt this micron thin SiN is going to stand up to corrosion very well.
So what material are you going to replace titanium plates and screws with?